News
Evidence-based medicine "Boy Wonder" Dr. Vinay Prasad was fired as CBER Director after less than three months on the job.
The FDA's top regulator of cancer drugs played a key role in the rejection of a skin cancer therapy from Replimune Group, ...
Vinay Prasad, a professor who until earlier this year headed a cancer-drugs and health-policy lab at UC San Francisco, ...
The FDA's top regulator of cancer drugs interceded in a review of a Replimune skin cancer therapy, contributing to its ...
Replimune (REPL) stock plummets as report suggests FDA’s top regulator of cancer drugs intervened in rejecting its lead asset ...
23hon MSNOpinion
Jamie Lee Curtis calls out Stephen Colbert for being 'in love with' her husband Christopher Guest: 'I'm fine with it' ...
The rejection occurred amid broader turmoil at the FDA, which has been experiencing leadership changes, staff upheaval, and internal dysfunction. These organizational issues reportedly factored into ...
Sarepta and Capricor learned of key regulatory decisions from the media and investors, and Duchenne muscular dystrophy ...
Janus Henderson reviews Q2 healthcare headwinds and standout biotech picks. Learn how the fund is navigating policy shifts ...
President Trump said Friday the U.S. is positioning two nuclear submarines in “appropriate regions” near Russia, a move he blamed on threatening rhetoric from former Russian President Dmitry Medvedev, ...
Laura Loomer has the ear of President Trump, and reports suggest members of his administration are going to her to root out ...
Tariff deadline approaches, consumers could feel the impact on goods while world leaders work on negotiations.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results